Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02166294 · ClinicalTrials.gov registry record · NA
NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
A NA study, sponsored by Amniox Medical.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02166294 is a NA study that was terminated before completion, run by Amniox Medical. The registered enrollment target is 18 participants.
The verdict
NCT02166294, a NA study, was terminated before completion, sponsored by Amniox Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
In this randomized, multi-center, cross-over study, the efficacy and safety of NEOX® CORD 1K will be evaluated in patients suffering from non-healing diabetic foot ulcers. NEOX® CORD 1K is a cryopreserved human Amniotic Membrane and Umbilical Cord (AM/UC) matrix intended for use as a wound covering for dermal ulcers and defects. It is designated as a Human Cell \& Tissue Product (HCT/P) by the U.S. FDA.
Interventions
- OTHER NEOX® CORD 1K
- PROCEDURE Standard of Care (Pressure Bandage)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2014-06 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02166294
The ClinicalTrials.gov registry entry for NCT02166294 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amniox Medical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NEOX® CORD 1K is the first listed.
NCT02166294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02166294 about?
NCT02166294 is a clinical study titled "NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers". In this randomized, multi-center, cross-over study, the efficacy and safety of NEOX® CORD 1K will be evaluated in patients suffering from non-healing diabetic foot ulcers. NEOX® CORD 1K is a cryopreserved human Amniotic Membrane and Umbilical Cord (AM/UC) matrix intended for use as a wound covering ...
What is the current status of trial NCT02166294?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2014-06. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02166294?
The interventions under investigation include: NEOX® CORD 1K (OTHER), Standard of Care (Pressure Bandage) (PROCEDURE).
Who is sponsoring clinical trial NCT02166294?
This trial is sponsored by Amniox Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.